Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 279 entries
Sorted by: Best Match Show Resources per page
Development of Bilateral Cam Deformity After Dunn Procedure and Contralateral Prophylactic Fixation: A Periosteal Reaction?: A Case Report.

JBJS case connector

Aepli M, Ganz R, Manner HM, Leunig M.
PMID: 29252706
JBJS Case Connect. 2015 Apr-Jun;5(2):e53. doi: 10.2106/JBJS.CC.N.00166.

CASE: We present the case of a fourteen-year-old male athlete with a slipped capital femoral epiphysis who was managed with a unilateral Dunn procedure and contralateral prophylactic screw fixation. Even though the cartilaginous epiphyseal growth plate was removed on...

Cite
Aepli M, Ganz R, Manner HM, et al. Development of Bilateral Cam Deformity After Dunn Procedure and Contralateral Prophylactic Fixation: A Periosteal Reaction?: A Case Report. JBJS Case Connect. 2015;5(2):e53doi: 10.2106/JBJS.CC.N.00166.
Aepli, M., Ganz, R., Manner, H. M., & Leunig, M. (2015). Development of Bilateral Cam Deformity After Dunn Procedure and Contralateral Prophylactic Fixation: A Periosteal Reaction?: A Case Report. JBJS case connector, 5(2), e53. https://doi.org/10.2106/JBJS.CC.N.00166
Aepli, Martin, et al. "Development of Bilateral Cam Deformity After Dunn Procedure and Contralateral Prophylactic Fixation: A Periosteal Reaction?: A Case Report." JBJS case connector vol. 5,2 (2015): e53. doi: https://doi.org/10.2106/JBJS.CC.N.00166
Aepli M, Ganz R, Manner HM, Leunig M. Development of Bilateral Cam Deformity After Dunn Procedure and Contralateral Prophylactic Fixation: A Periosteal Reaction?: A Case Report. JBJS Case Connect. 2015 Apr-Jun;5(2):e53. doi: 10.2106/JBJS.CC.N.00166. PMID: 29252706.
Copy Download .nbib Format: NLM
[GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.].

Recenti progressi in medicina

Morgano GP, Amato L, Parmelli E, Moja L, Davoli M, Schünemann H.
PMID: 29105695
Recenti Prog Med. 2017 Oct;108(10):402-424. doi: 10.1701/2802.28354.

Following the development of a unifying and transparent approach to grading the certainty of evidence and strength or recommendations, the GRADE (Grading of Recommendations Assessment, Development and Evaluation) Working Group has refined its process of moving from Evidence to...

Cite
Morgano GP, Amato L, Parmelli E, et al. GRADE Evidence to Decision (EtD) framework: un approccio sistematico e trasparente per prendere decisioni informate in ambito sanitario. 1: Introduzione. [GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.]. Recenti Prog Med. 2017;108(10):402-424doi: 10.1701/2802.28354.
Morgano, G. P., Amato, L., Parmelli, E., Moja, L., Davoli, M., & Schünemann, H. (2017). GRADE Evidence to Decision (EtD) framework: un approccio sistematico e trasparente per prendere decisioni informate in ambito sanitario. 1: Introduzione. [GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.]. Recenti progressi in medicina, 108(10), 402-424. https://doi.org/10.1701/2802.28354
Morgano, Gian Paolo, et al. "GRADE Evidence to Decision (EtD) framework: un approccio sistematico e trasparente per prendere decisioni informate in ambito sanitario. 1: Introduzione." [GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.]. Recenti progressi in medicina vol. 108,10 (2017): 402-424. doi: https://doi.org/10.1701/2802.28354
Morgano GP, Amato L, Parmelli E, Moja L, Davoli M, Schünemann H. GRADE Evidence to Decision (EtD) framework: un approccio sistematico e trasparente per prendere decisioni informate in ambito sanitario. 1: Introduzione. [GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.]. Recenti Prog Med. 2017 Oct;108(10):402-424. doi: 10.1701/2802.28354. Italian. PMID: 29105695.
Copy Download .nbib Format: NLM
Reconstruction of H3N2 influenza virus based virosome in-vitro.

Iranian journal of microbiology

Abdoli A, Soleimanjahi H, Kheiri MT, Jamali A, Sohani H, Abdoli M, Rahmatollahi HR.
PMID: 23825736
Iran J Microbiol. 2013 Jun;5(2):166-71.

BACKGROUND AND OBJECTIVES: Virosomes are Virus Like Particles (VLP) assembled in-vitro. Influenza virosomes maintain the cell binding and membrane fusion activity of the wild type virus but are devoid of viral genetic material or internal proteins. Influenza virosomes mimic...

Cite
Abdoli A, Soleimanjahi H, Kheiri MT, et al. Reconstruction of H3N2 influenza virus based virosome in-vitro. Iran J Microbiol. 2013;5(2):166-71
Abdoli, A., Soleimanjahi, H., Kheiri, M. T., Jamali, A., Sohani, H., Abdoli, M., & Rahmatollahi, H. R. (2013). Reconstruction of H3N2 influenza virus based virosome in-vitro. Iranian journal of microbiology, 5(2), 166-71.
Abdoli, Asghar, et al. "Reconstruction of H3N2 influenza virus based virosome in-vitro." Iranian journal of microbiology vol. 5,2 (2013): 166-71.
Abdoli A, Soleimanjahi H, Kheiri MT, Jamali A, Sohani H, Abdoli M, Rahmatollahi HR. Reconstruction of H3N2 influenza virus based virosome in-vitro. Iran J Microbiol. 2013 Jun;5(2):166-71. PMID: 23825736; PMCID: PMC3696854.
Copy Download .nbib Format: NLM
Supplementary Data.

Recenti progressi in medicina

Amato L, Vecchi S, Barbui C, Cruciani F, D'Amico R, Del Giovane C, Minozzi S, Mitrova Z, Saulle R, Davoli M.
PMID: 30394409
Recenti Prog Med. 2018 Oct;109(10):1e-19e. doi: 10.1701/3010.30090.

No abstract available.

Cite
Amato L, Vecchi S, Barbui C, et al. Dati supplementari. Supplementary Data. Recenti Prog Med. 2018;109(10):1e-19edoi: 10.1701/3010.30090.
Amato, L., Vecchi, S., Barbui, C., Cruciani, F., D'Amico, R., Del Giovane, C., Minozzi, S., Mitrova, Z., Saulle, R., & Davoli, M. (2018). Dati supplementari. Supplementary Data. Recenti progressi in medicina, 109(10), 1e-19e. https://doi.org/10.1701/3010.30090
Amato, Laura, et al. "Dati supplementari." Supplementary Data. Recenti progressi in medicina vol. 109,10 (2018): 1e-19e. doi: https://doi.org/10.1701/3010.30090
Amato L, Vecchi S, Barbui C, Cruciani F, D'Amico R, Del Giovane C, Minozzi S, Mitrova Z, Saulle R, Davoli M. Dati supplementari. Supplementary Data. Recenti Prog Med. 2018 Oct;109(10):1e-19e. doi: 10.1701/3010.30090. Italian. PMID: 30394409.
Copy Download .nbib Format: NLM
Continuation of medically necessary platelet aggregation inhibitors - acetylsalicylic acid and clopidogrel - during surgery for spinal degenerative disorders: Results in 100 patients.

Surgical neurology international

Akhavan-Sigari R, Rohde V, Abili M.
PMID: 25289165
Surg Neurol Int. 2014 Aug 28;5:S376-9. doi: 10.4103/2152-7806.139675. eCollection 2014.

BACKGROUND: Patients undergoing spinal surgery while under anticoagulation therapy are at risk of developing bleeding complications, even though lower incidences have been reported for joint arthroplasty surgery. There is a gap in the medical literature examining the incidence of...

Cite
Akhavan-Sigari R, Rohde V, Abili M. Continuation of medically necessary platelet aggregation inhibitors - acetylsalicylic acid and clopidogrel - during surgery for spinal degenerative disorders: Results in 100 patients. Surg Neurol Int. 2014;5:S376-9doi: 10.4103/2152-7806.139675.
Akhavan-Sigari, R., Rohde, V., & Abili, M. (2014). Continuation of medically necessary platelet aggregation inhibitors - acetylsalicylic acid and clopidogrel - during surgery for spinal degenerative disorders: Results in 100 patients. Surgical neurology international, 5S376-9. https://doi.org/10.4103/2152-7806.139675
Akhavan-Sigari, Reza, et al. "Continuation of medically necessary platelet aggregation inhibitors - acetylsalicylic acid and clopidogrel - during surgery for spinal degenerative disorders: Results in 100 patients." Surgical neurology international vol. 5 (2014): S376-9. doi: https://doi.org/10.4103/2152-7806.139675
Akhavan-Sigari R, Rohde V, Abili M. Continuation of medically necessary platelet aggregation inhibitors - acetylsalicylic acid and clopidogrel - during surgery for spinal degenerative disorders: Results in 100 patients. Surg Neurol Int. 2014 Aug 28;5:S376-9. doi: 10.4103/2152-7806.139675. eCollection 2014. PMID: 25289165; PMCID: PMC4173210.
Copy Download .nbib Format: NLM
A 40-year-old man with testicular torsion and large bilateral spermatoceles.

Qatar medical journal

Ameli M, Parsapour A, Gholami-Mahtaj L.
PMID: 28058232
Qatar Med J. 2016 Dec 24;2016(2):10. doi: 10.5339/qmj.2016.10. eCollection 2016.

Testicular torsion is a rare disease that mostly involves children. Peak incidence is in infancy and in adolescence. Testicular torsion is rarely seen in men over 40 years of age and has only once been accompanied with spermatocele. We...

Cite
Ameli M, Parsapour A, Gholami-Mahtaj L. A 40-year-old man with testicular torsion and large bilateral spermatoceles. Qatar Med J. 2016;2016(2):10doi: 10.5339/qmj.2016.10.
Ameli, M., Parsapour, A., & Gholami-Mahtaj, L. (2016). A 40-year-old man with testicular torsion and large bilateral spermatoceles. Qatar medical journal, 2016(2), 10. https://doi.org/10.5339/qmj.2016.10
Ameli, Mojtaba, et al. "A 40-year-old man with testicular torsion and large bilateral spermatoceles." Qatar medical journal vol. 2016,2 (2016): 10. doi: https://doi.org/10.5339/qmj.2016.10
Ameli M, Parsapour A, Gholami-Mahtaj L. A 40-year-old man with testicular torsion and large bilateral spermatoceles. Qatar Med J. 2016 Dec 24;2016(2):10. doi: 10.5339/qmj.2016.10. eCollection 2016. PMID: 28058232; PMCID: PMC5200847.
Copy Download .nbib Format: NLM
Ecological homogenization of residential macrosystems.

Nature ecology & evolution

Groffman PM, Avolio M, Cavender-Bares J, Bettez ND, Grove JM, Hall SJ, Hobbie SE, Larson KL, Lerman SB, Locke DH, Heffernan JB, Morse JL, Neill C, Nelson KC, O'Neil-Dunne J, Pataki DE, Polsky C, Chowdhury RR, Trammell TLE.
PMID: 28812594
Nat Ecol Evol. 2017 Jun 22;1(7):191. doi: 10.1038/s41559-017-0191.

No abstract available.

Cite
Groffman PM, Avolio M, Cavender-Bares J, et al. Ecological homogenization of residential macrosystems. Nat Ecol Evol. 2017;1(7):191doi: 10.1038/s41559-017-0191.
Groffman, P. M., Avolio, M., Cavender-Bares, J., Bettez, N. D., Grove, J. M., Hall, S. J., Hobbie, S. E., Larson, K. L., Lerman, S. B., Locke, D. H., Heffernan, J. B., Morse, J. L., Neill, C., Nelson, K. C., O'Neil-Dunne, J., Pataki, D. E., Polsky, C., Chowdhury, R. R., & Trammell, T. L. E. (2017). Ecological homogenization of residential macrosystems. Nature ecology & evolution, 1(7), 191. https://doi.org/10.1038/s41559-017-0191
Groffman, Peter M, et al. "Ecological homogenization of residential macrosystems." Nature ecology & evolution vol. 1,7 (2017): 191. doi: https://doi.org/10.1038/s41559-017-0191
Groffman PM, Avolio M, Cavender-Bares J, Bettez ND, Grove JM, Hall SJ, Hobbie SE, Larson KL, Lerman SB, Locke DH, Heffernan JB, Morse JL, Neill C, Nelson KC, O'Neil-Dunne J, Pataki DE, Polsky C, Chowdhury RR, Trammell TLE. Ecological homogenization of residential macrosystems. Nat Ecol Evol. 2017 Jun 22;1(7):191. doi: 10.1038/s41559-017-0191. PMID: 28812594.
Copy Download .nbib Format: NLM
Palivizumab reimbursement criteria and neonatal RSV hospitalisation: a regional retrospective review.

BMJ paediatrics open

Belleudi V, Marchetti F, Finocchietti M, Davoli M, Addis A.
PMID: 33748434
BMJ Paediatr Open. 2021 Mar 01;5(1):e000985. doi: 10.1136/bmjpo-2020-000985. eCollection 2021.

In Italy, reimbursement restrictions regarding palivizumab prophylaxis approved in 2016 have been revoked in 2017, restoring use in infants with Gestational Age (GA) >29 weeks. Respiratory Syncytial Virus (RSV) hospitalisations and prevalence of palivizumab use in infants aged

Cite
Belleudi V, Marchetti F, Finocchietti M, et al. Palivizumab reimbursement criteria and neonatal RSV hospitalisation: a regional retrospective review. BMJ Paediatr Open. 2021;5(1):e000985doi: 10.1136/bmjpo-2020-000985.
Belleudi, V., Marchetti, F., Finocchietti, M., Davoli, M., & Addis, A. (2021). Palivizumab reimbursement criteria and neonatal RSV hospitalisation: a regional retrospective review. BMJ paediatrics open, 5(1), e000985. https://doi.org/10.1136/bmjpo-2020-000985
Belleudi, Valeria, et al. "Palivizumab reimbursement criteria and neonatal RSV hospitalisation: a regional retrospective review." BMJ paediatrics open vol. 5,1 (2021): e000985. doi: https://doi.org/10.1136/bmjpo-2020-000985
Belleudi V, Marchetti F, Finocchietti M, Davoli M, Addis A. Palivizumab reimbursement criteria and neonatal RSV hospitalisation: a regional retrospective review. BMJ Paediatr Open. 2021 Mar 01;5(1):e000985. doi: 10.1136/bmjpo-2020-000985. eCollection 2021. PMID: 33748434; PMCID: PMC7925248.
Copy Download .nbib Format: NLM
Covalent Decoration of MoS.

Langmuir : the ACS journal of surfaces and colloids

Souri Z, Adeli M, Mehdipour E, Yari A, Shams A, Beyranvand S, Sattari S.
PMID: 33691410
Langmuir. 2021 Mar 23;37(11):3382-3390. doi: 10.1021/acs.langmuir.0c03518. Epub 2021 Mar 10.

Two-dimensional nanomaterials decorated by metal nanoparticles have gained great interest, due to their potential applications in different areas ranging from electrochemical sensing to photothermal therapy. However, metal nanoparticles that are noncovalently immobilized on the surface of two-dimensional nanomaterials can...

Cite
Souri Z, Adeli M, Mehdipour E, et al. Covalent Decoration of MoS. Langmuir. 2021;37(11):3382-3390doi: 10.1021/acs.langmuir.0c03518.
Souri, Z., Adeli, M., Mehdipour, E., Yari, A., Shams, A., Beyranvand, S., & Sattari, S. (2021). Covalent Decoration of MoS. Langmuir : the ACS journal of surfaces and colloids, 37(11), 3382-3390. https://doi.org/10.1021/acs.langmuir.0c03518
Souri, Zeinab, et al. "Covalent Decoration of MoS." Langmuir : the ACS journal of surfaces and colloids vol. 37,11 (2021): 3382-3390. doi: https://doi.org/10.1021/acs.langmuir.0c03518
Souri Z, Adeli M, Mehdipour E, Yari A, Shams A, Beyranvand S, Sattari S. Covalent Decoration of MoS. Langmuir. 2021 Mar 23;37(11):3382-3390. doi: 10.1021/acs.langmuir.0c03518. Epub 2021 Mar 10. PMID: 33691410.
Copy Download .nbib Format: NLM
Gestational breast cancer in a patient with Crohn's disease: two case reports.

Journal of medical case reports

Al-Arsan Al-Yaseen M, Haydar SA, Alali M, Saifo M.
PMID: 34961553
J Med Case Rep. 2021 Dec 27;15(1):633. doi: 10.1186/s13256-021-03224-3.

BACKGROUND: Diagnosis of breast cancer during gestation is a rare occurrence. In addition, the diagnosis of breast cancer in a patient with Crohn's disease is not common. We present a rare case of gestational breast cancer in a patient...

Cite
Al-Arsan Al-Yaseen M, Haydar SA, Alali M, et al. Gestational breast cancer in a patient with Crohn's disease: two case reports. J Med Case Rep. 2021;15(1):633doi: 10.1186/s13256-021-03224-3.
Al-Arsan Al-Yaseen, M., Haydar, S. A., Alali, M., & Saifo, M. (2021). Gestational breast cancer in a patient with Crohn's disease: two case reports. Journal of medical case reports, 15(1), 633. https://doi.org/10.1186/s13256-021-03224-3
Al-Arsan Al-Yaseen, Mohammed, et al. "Gestational breast cancer in a patient with Crohn's disease: two case reports." Journal of medical case reports vol. 15,1 (2021): 633. doi: https://doi.org/10.1186/s13256-021-03224-3
Al-Arsan Al-Yaseen M, Haydar SA, Alali M, Saifo M. Gestational breast cancer in a patient with Crohn's disease: two case reports. J Med Case Rep. 2021 Dec 27;15(1):633. doi: 10.1186/s13256-021-03224-3. PMID: 34961553.
Copy Download .nbib Format: NLM
Yolk hormones and sexual conflict over parental investment in the pied flycatcher.

Behavioral ecology and sociobiology

Laaksonen T, Adamczyk F, Ahola M, Möstl E, Lessells CK.
PMID: 22081740
Behav Ecol Sociobiol. 2011 Feb;65(2):257-264. doi: 10.1007/s00265-010-1034-9. Epub 2010 Aug 13.

Female birds might be able to manipulate the parental effort of their male partner through elevated transfer of hormones to the eggs, since these hormones affect many chick traits that males might use as cues for adjusting the level...

Cite
Laaksonen T, Adamczyk F, Ahola M, et al. Yolk hormones and sexual conflict over parental investment in the pied flycatcher. Behav Ecol Sociobiol. 2010;65(2):257-264doi: 10.1007/s00265-010-1034-9.
Laaksonen, T., Adamczyk, F., Ahola, M., Möstl, E., & Lessells, C. K. (2011). Yolk hormones and sexual conflict over parental investment in the pied flycatcher. Behavioral ecology and sociobiology, 65(2), 257-264. https://doi.org/10.1007/s00265-010-1034-9
Laaksonen, Toni, et al. "Yolk hormones and sexual conflict over parental investment in the pied flycatcher." Behavioral ecology and sociobiology vol. 65,2 (2011): 257-264. doi: https://doi.org/10.1007/s00265-010-1034-9
Laaksonen T, Adamczyk F, Ahola M, Möstl E, Lessells CK. Yolk hormones and sexual conflict over parental investment in the pied flycatcher. Behav Ecol Sociobiol. 2011 Feb;65(2):257-264. doi: 10.1007/s00265-010-1034-9. Epub 2010 Aug 13. PMID: 22081740; PMCID: PMC3197946.
Copy Download .nbib Format: NLM
The Standard of Care Definitions on COVID-19 Pharmacological Clinical Trials: A Systematic Review.

Frontiers in pharmacology

Addis A, Amato L, Cruciani F, Saulle R, De Crescenzo F, Mitrova Z, Vecchi S, Perrone F, Davoli M.
PMID: 34733161
Front Pharmacol. 2021 Oct 18;12:749514. doi: 10.3389/fphar.2021.749514. eCollection 2021.

No abstract available.

Cite
Addis A, Amato L, Cruciani F, et al. The Standard of Care Definitions on COVID-19 Pharmacological Clinical Trials: A Systematic Review. Front Pharmacol. 2021;12:749514doi: 10.3389/fphar.2021.749514.
Addis, A., Amato, L., Cruciani, F., Saulle, R., De Crescenzo, F., Mitrova, Z., Vecchi, S., Perrone, F., & Davoli, M. (2021). The Standard of Care Definitions on COVID-19 Pharmacological Clinical Trials: A Systematic Review. Frontiers in pharmacology, 12749514. https://doi.org/10.3389/fphar.2021.749514
Addis, Antonio, et al. "The Standard of Care Definitions on COVID-19 Pharmacological Clinical Trials: A Systematic Review." Frontiers in pharmacology vol. 12 (2021): 749514. doi: https://doi.org/10.3389/fphar.2021.749514
Addis A, Amato L, Cruciani F, Saulle R, De Crescenzo F, Mitrova Z, Vecchi S, Perrone F, Davoli M. The Standard of Care Definitions on COVID-19 Pharmacological Clinical Trials: A Systematic Review. Front Pharmacol. 2021 Oct 18;12:749514. doi: 10.3389/fphar.2021.749514. eCollection 2021. PMID: 34733161; PMCID: PMC8558371.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 279 entries